Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

847
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
847

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.

Brain sciences·2026
Same author

Predictors of Mortality and Outcomes in Older Adult Burn Patient Subgroups: A Comparative Meta-analysis of Age, Burn Severity, and Intervention Strategies.

Plastic and reconstructive surgery. Global open·2026
Same author

Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.

Frontiers in public health·2026
Same author

Advanced Research in Neuroprotection.

Biomedicines·2026
Same author

Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

From Dish to Trial: Building Translational Models of ALS.

Cells·2026

相关实验视频

Updated: Jul 5, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K

早期多发性硬化症有多早?

Sotiria Stavropoulou De Lorenzo1, Christos Bakirtzis1, Natalia Konstantinidou1

  • 1Multiple Sclerosis Center, Second Department of Neurology, School of Medicine, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.

Journal of clinical medicine
|January 11, 2024
PubMed
概括

多发性硬化症 (MS) 的早期诊断至关重要. 本综述探讨了放射性隔离综合征 (RIS) 的生物标志物,以识别在症状出现之前进展为MS的患者.

关键词:
这里是RIS RIS.疾病的进展 疾病的进展早期治疗 早期治疗实验室生物标志物实验室生物标志物多发性硬化症多发性硬化症多发性硬化症前症候群 多发性硬化症前症候群神经成像生物标记物

更多相关视频

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.6K

相关实验视频

Last Updated: Jul 5, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.6K

科学领域:

  • 神经免疫学 神经免疫学
  • 神经学 神经学
  • 生物标志物发现发现

背景情况:

  • 优化多发性硬化症 (MS) 的诊断标准是早期和准确诊断的关键.
  • 早期MS治疗与疾病进展缓慢和更好的长期结果有关.
  • 神经炎症和神经退行过程可能会在MS中出现症状.

研究的目的:

  • 审查有关多发性硬化病理和早期检测潜在生物标志物的当前研究.
  • 为了确定患有放射性隔离综合征 (RIS) 的个体,他们有很高的风险发展为MS.
  • 提高临床医生对亚临床MS和新兴生物标志物的认识,以便在未来临床使用.

主要方法:

  • 对MS病理学研究的综合文献综述.
  • 对MS风险分层的实验室和神经成像生物标志物的研究分析.
  • 专注于生物标志物,以识别可能转化为确定的MS的RIS个体.

主要成果:

  • 在MS症状显现之前,神经炎症和神经退行性过程可能发生.
  • 很大一部分RIS患者最终会发展为MS.
  • 目前,RIS还没有批准的治疗方法,这凸显了早期检测生物标志物的必要性.

结论:

  • 准确的生物标志物对于识别将发展为MS的RIS个体至关重要.
  • 通过生物标志物早期检测亚临床MS可以实现及时干预.
  • 需要进一步的研究和生物标志物的验证,以便在管理RIS的临床应用.